BECK MACK & OLIVER LLC - RegeneRx Biopharmaceuticals ownership

Back to all holdings Add to watchlist

RegeneRx Biopharmaceuticals's ticker is RGRX and the CUSIP is 75886X108. A total of 1 filers reported holding RegeneRx Biopharmaceuticals in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
BECK MACK & OLIVER LLC ownership history of RegeneRx Biopharmaceuticals
ValueSharesWeighting
Q4 2015$8,000
+14.3%
18,0000.0%0.00%–
Q3 2015$7,000–18,000–0.00%–
 Download
Other shareholders
RegeneRx Biopharmaceuticals shareholders Q3 2023
NameSharesValueWeighting ↓
Williams Jones Wealth Management, LLC. 10,000$1700.00%
View complete list of RegeneRx Biopharmaceuticals shareholders